Australia makes cautious entry into medicinal marijuana market
It signals intention for homegrown industry after Canada, Israel and many US states legalise the plant for medicine
Melbourne
AT a secret location in Australia's south-east, Peter Crook delicately tends to a two-month-old cannabis cutting.
Barely knee high, it is one of about 50 government-sanctioned "mother plants" to be cloned for future generations of crops for the country's fledgling medicinal marijuana industry.
"I think we'll see Australia punch above its weight, both in agriculture research as well as medical technology," says Mr Crook, chief executive of Cann Group, the firm granted Australia's first commercial grower's licence. "As different conditions come online we are going to see the market grow rapidly."
Following Canada, Israel, and more than half of the US states, which through varying approaches have le…
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Starbucks set for talks with unionised US stores
Gucci-owner Kering posts 10% drop in Q1 sales on sluggish Chinese demand
China bubble-tea chain Chabaidao plunges on Hong Kong debut
Japan’s 7-Eleven convenience chain targets aggressive global growth
Parental fury after stem cell bank ruins thousands of samples in Singapore
China’s bubble tea boom creates a half-dozen billionaires